SEP 23, 2016 9:36 AM PDT

Magnetic bacteria target tumors

WRITTEN BY: Kerry Evans
Holy magnetic bacteria, Batman! Researchers at the Polytechnique Montreal NanoRobotics Laboratory want to use magnetic bacteria to traffic drugs to tumors.

First of all, magnetic bacteria? Yes, they’re a real thing. Magnetococcus marinus is a bacterium that lives deep down in the ocean where oxygen is scarce. Magnetococcus contains a magnetosome - a structure that contains between 15 and 20 magnetite crystals. These magnetic crystals act like a tiny compass that orients the cell with the Earth’s magnetic field. Odd thing is, these magnets also help the bacteria find environments with very little oxygen (that’s a topic for another time).
Magnetococcus contains magnetosomes.
So, what do magnetic bacteria that like hypoxic environments have to do with cancer? One problem with systemic cancer therapy is that it’s systemic. If a cancer drug isn’t targeted specifically to the cancer, healthy cells also suffer (and that’s not good). To solve that, researchers are developing so-called nanocarriers to deliver drugs specifically to tumors. The problem is, however, that the nanocarriers have trouble making it to the inside of a tumor. Incidentally, the inside of a tumor is usually hypoxic. Magnetic bacteria to the rescue!

The idea is that a magnetic field can be generated to direct the bacteria to the tumor. Then, it’s up to the bacteria to find their way into the hypoxic zone of the tumor. I should also mention - vesicles containing cancer drugs would be attached to the bacteria.

According to study author Sylvain Martel, “When they get inside the tumor, we switch off the magnetic field and the bacteria automatically rely on [their] oxygen sensors to seek out the hypoxic areas. We constrain them to the tumor and then let nature do the rest.”

As proof-of-concept, Martel and colleagues tested this system in mice afflicted with human colorectal tumors. First, they wanted to know whether the bacteria could traffic to and penetrate a tumor. They injected mice with live bacteria, dead bacteria, or non-magnetic beads. Very few dead bacteria or non-magnetic beads made their way into the tumors, but a significant number of live bacteria did.

Next, they attached drug-loaded vesicles to the bacteria (around 70 vesicles per bacterium) to see how this would affect their movement into the tumors. They found that roughly 55% of the vesicle-loaded bacteria penetrated the tumors. That’s huge, considering only around 2% of nanocarriers are delivered to tumors!

But wait, are you wondering if it’s a good idea to inject live bacteria into live people? Well, Magnetococcus is not a pathogen, and the researchers insist that they only survive for about 30 minutes after injection.
 

Source: National Institute of Biomedical Imaging and Bioengineering, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAY 05, 2020
Cell & Molecular Biology
Preprint Suggests Sars-CoV-2 Mutation Makes it More Transmissable
MAY 05, 2020
Preprint Suggests Sars-CoV-2 Mutation Makes it More Transmissable
Samples obtained from patients from all over the world have been used to sequence the genomes of the viral strains infec ...
MAY 09, 2020
Clinical & Molecular DX
Rapid, Efficient COVID-19 Diagnostic Method Relies on Magnetic Beads
MAY 09, 2020
Rapid, Efficient COVID-19 Diagnostic Method Relies on Magnetic Beads
The pandemic virus SARS-CoV-2 has spread widely, and a lack of testing has been a serious problem.
MAY 14, 2020
Microbiology
Cats Can Get Infected by SARS-CoV-2 and Transmit It to Other Cats
MAY 14, 2020
Cats Can Get Infected by SARS-CoV-2 and Transmit It to Other Cats
New research reported in the New England Journal of Medicine has indicated that domestic cats can easily be infected wit ...
JUN 16, 2020
Microbiology
Dexamethasone Hailed as Effective COVID-19 Treatment
JUN 16, 2020
Dexamethasone Hailed as Effective COVID-19 Treatment
The pandemic virus SARS-CoV-2, which causes COVID-19, has killed more than 438,000 people worldwide since it emerged lat ...
JUL 23, 2020
Genetics & Genomics
A Human Protein Can Mutate SARS-CoV-2, But It Can Change Back
JUL 23, 2020
A Human Protein Can Mutate SARS-CoV-2, But It Can Change Back
One way the human body can try to fight the coronavirus is by mutating it; these mutations seem to disrupt it. But the v ...
AUG 04, 2020
Microbiology
Johns Hopkins is Starting COVID-19 Plasma Trials
AUG 04, 2020
Johns Hopkins is Starting COVID-19 Plasma Trials
Researchers at JHU are starting a controlled trial that aims to learn whether plasma from recovered COVID-19 patients ca ...
Loading Comments...